JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,625 articles

Articles by James Calloway

Nu Holdings Taps Chanes to Lead LatAm as Mexico Deposits Outpace Customer Share
Earnings

Nu Holdings Taps Chanes to Lead LatAm as Mexico Deposits Outpace Customer Share

Nu Holdings (NYSE:NU) puts Livia Chanes in charge of Latin American operations as Mexico's deposit share (14%) exceeds its customer share (11%), signaling a shift from growth to monetization.

NU
American Airlines Q2 Earnings at Risk from $221 Million Fuel Cost Gap
Earnings

American Airlines Q2 Earnings at Risk from $221 Million Fuel Cost Gap

American Airlines faces a $221 million fuel cost swing in Q2, with actual prices exceeding its April forecast. The carrier's earnings, due July 23, hinge on revenue recovery and cost management.

AAL UAL
HSBC's Hong Kong Rate Boost Supports $46 Billion Income Target
Earnings

HSBC's Hong Kong Rate Boost Supports $46 Billion Income Target

HSBC gains a rate cushion as one-month HIBOR rises 32.8 bps above its preferred range, supporting its $46 billion income target.

HSBC
Experian Shares Dip as B2B Drives 92% of Q1 Growth, Consumer Weakens
Earnings

Experian Shares Dip as B2B Drives 92% of Q1 Growth, Consumer Weakens

Experian posted 7% organic revenue growth in Q1, but North American Consumer Services shrank 2%. B2B drove 92% of implied growth, up from 78% last year. Shares fell 2.1%.

TSMC Profit Per Wafer Surges 42% as AI Demand Drives Record Earnings
Earnings

TSMC Profit Per Wafer Surges 42% as AI Demand Drives Record Earnings

TSMC reports record Q2 earnings with profit per wafer up 42% on AI demand. Revenue rose 36% to NT$1.27T, operating income up 65.4%. Capex outlook raised to $60-$64B.

TSM AMD NVDA
CBA's A$92 Billion Premium Faces Test as August Results Loom
Earnings

CBA's A$92 Billion Premium Faces Test as August Results Loom

Commonwealth Bank of Australia (ASX:CBA) enters Thursday with a A$92 billion market value premium versus major rivals, as investors await August 12 results to justify the stock's steep valuation.

CBAUF ANZBY
Tesla's Q2 Delivery Beat Driven by Inventory Drawdown, Margin Focus Intensifies
Earnings

Tesla's Q2 Delivery Beat Driven by Inventory Drawdown, Margin Focus Intensifies

Tesla delivered 480,126 vehicles in Q2, beating consensus by 18.3%, as inventory drawdown contributed 38% of the beat. Margins are now the key focus.

TSLA MS WFC
Chipotle's Mexico Entry: A Growth Test, Not an Earnings Catalyst
Earnings

Chipotle's Mexico Entry: A Growth Test, Not an Earnings Catalyst

Chipotle (CMG) opens its first restaurant in Mexico, but the move is a long-term growth test rather than a near-term earnings driver. International partner stores remain a tiny fraction of operations.

CMG
Publix Closures Amid $2.4B Upgrade and Flat Sales
Earnings

Publix Closures Amid $2.4B Upgrade and Flat Sales

Publix closed eight stores in Q1, with seven replaced or set for replacement, as capital spending jumped 45% and comparable sales stalled.

J.B. Hunt Intermodal Drives 89% of Profit Surge in Q2
Earnings

J.B. Hunt Intermodal Drives 89% of Profit Surge in Q2

J.B. Hunt's intermodal unit accounted for $55.1 million of its $62.2 million operating profit increase in Q2, driving shares up 6.9% after hours.

JBHT
JetBlue Introduces Pay-Later Option Amid Rising Fuel Costs
Earnings

JetBlue Introduces Pay-Later Option Amid Rising Fuel Costs

JetBlue Airways (JBLU) has launched a pay-later option, ClarityPay, to drive sales as rising fuel costs offset fare hike gains. Q2 guidance indicates a revenue shortfall of $185 million.

JBLU UAL SPGI
Pfizer Stock Rises as Sanofi Files Patent Suit Over COVID Vaccine Revenue
Regulation

Pfizer Stock Rises as Sanofi Files Patent Suit Over COVID Vaccine Revenue

Pfizer shares gained 2.35% as Sanofi's patent lawsuit over Comirnaty targets past revenue rather than current sales, with modest financial risk relative to cash reserves.

PFE SNY MRNA